Clinical Trials Directory

Trials / Completed

CompletedNCT01938755

Hyperbaric Levobupivacaine for Spinal Anaesthesia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
73 (actual)
Sponsor
Ordu University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Spinal anaesthesia also called spinal block or sub-arachnoid block (SAB), is a form of regional anaesthesia involving injection of a local anaesthetic into the subarachnoid space, generally through a fine needle. There is no generic hyperbaric form of levobupivacaine currently available so we aimed in this study that to find the appropriate concentration of the levobupivacaine which achieves unilateral spinal anesthesia. The potential benefits of this type of anesthesia are less motor blockade and urinary retention, decrease in hospital stay. Therefore, it seems to be suitable for outpatient anesthesia.

Conditions

Interventions

TypeNameDescription
DRUGlevobupivacainelevobupivacaine plus 60 mg dextrose
DRUGlevobupivacainelevobupivacaine plus 80 mg dextrose
DRUGlevobupivacainelevobupivacaine plus 100 mg dextrose

Timeline

Start date
2013-06-01
Primary completion
2014-01-01
Completion
2014-01-01
First posted
2013-09-10
Last updated
2017-04-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01938755. Inclusion in this directory is not an endorsement.